Sarah L Ferri1, Ted Abel1, Edward S Brodkin2. 1. Department of Molecular Physiology and Biophysics, Iowa Neuroscience Institute, University of Iowa, Pappajohn Biomedical Discovery Building, 169 Newton Road, Iowa City, IA, 52242, USA. 2. Center for Neurobiology and Behavior, Department of Psychiatry, Translational Research Laboratory, Perelman School of Medicine at the University of Pennsylvania, 125 South 31st Street, Room 2202, Philadelphia, PA, 19104-3403, USA. ebrodkin@pennmedicine.upenn.edu.
Abstract
PURPOSE OF REVIEW: Neurodevelopmental disorders disproportionately affect males. The mechanisms underlying male vulnerability or female protection are not known and remain understudied. Determining the processes involved is crucial to understanding the etiology and advancing treatment of neurodevelopmental disorders. Here, we review current findings and theories that contribute to male preponderance of neurodevelopmental disorders, with a focus on autism. RECENT FINDINGS: Recent work on the biological basis of the male preponderance of autism and other neurodevelopmental disorders includes discussion of a higher genetic burden in females and sex-specific gene mutations or epigenetic changes that differentially confer risk to males or protection to females. Other mechanisms discussed are sex chromosome and sex hormone involvement. Specifically, fetal testosterone is involved in many aspects of development and may interact with neurotransmitter, neuropeptide, or immune pathways to contribute to male vulnerability. Finally, the possibilities of female underdiagnosis and a multi-hit hypothesis are discussed. This review highlights current theories of male bias in developmental disorders. Topics include environmental, genetic, and epigenetic mechanisms; theories of sex chromosomes, hormones, neuroendocrine, and immune function; underdiagnosis of females; and a multi-hit hypothesis.
PURPOSE OF REVIEW: Neurodevelopmental disorders disproportionately affect males. The mechanisms underlying male vulnerability or female protection are not known and remain understudied. Determining the processes involved is crucial to understanding the etiology and advancing treatment of neurodevelopmental disorders. Here, we review current findings and theories that contribute to male preponderance of neurodevelopmental disorders, with a focus on autism. RECENT FINDINGS: Recent work on the biological basis of the male preponderance of autism and other neurodevelopmental disorders includes discussion of a higher genetic burden in females and sex-specific gene mutations or epigenetic changes that differentially confer risk to males or protection to females. Other mechanisms discussed are sex chromosome and sex hormone involvement. Specifically, fetal testosterone is involved in many aspects of development and may interact with neurotransmitter, neuropeptide, or immune pathways to contribute to male vulnerability. Finally, the possibilities of female underdiagnosis and a multi-hit hypothesis are discussed. This review highlights current theories of male bias in developmental disorders. Topics include environmental, genetic, and epigenetic mechanisms; theories of sex chromosomes, hormones, neuroendocrine, and immune function; underdiagnosis of females; and a multi-hit hypothesis.
Entities:
Keywords:
Autism; Extreme male brain theory; Female protective effect; Fetal testosterone; Neurodevelopmental disorders; Sex differences
Authors: Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer Journal: Neuron Date: 2014-08-21 Impact factor: 17.173
Authors: N Amram; G Hacohen-Kleiman; S Sragovich; A Malishkevich; J Katz; O Touloumi; R Lagoudaki; N C Grigoriadis; E Giladi; A Yeheskel; M Pasmanik-Chor; Y Jouroukhin; I Gozes Journal: Mol Psychiatry Date: 2016-01-19 Impact factor: 15.992
Authors: Daisuke Sato; Anath C Lionel; Claire S Leblond; Aparna Prasad; Dalila Pinto; Susan Walker; Irene O'Connor; Carolyn Russell; Irene E Drmic; Fadi F Hamdan; Jacques L Michaud; Volker Endris; Ralph Roeth; Richard Delorme; Guillaume Huguet; Marion Leboyer; Maria Rastam; Christopher Gillberg; Mark Lathrop; Dimitri J Stavropoulos; Evdokia Anagnostou; Rosanna Weksberg; Eric Fombonne; Lonnie Zwaigenbaum; Bridget A Fernandez; Wendy Roberts; Gudrun A Rappold; Christian R Marshall; Thomas Bourgeron; Peter Szatmari; Stephen W Scherer Journal: Am J Hum Genet Date: 2012-04-12 Impact factor: 11.025
Authors: Anita Beggiato; Hugo Peyre; Anna Maruani; Isabelle Scheid; Maria Rastam; Frederique Amsellem; Carina I Gillberg; Marion Leboyer; Thomas Bourgeron; Christopher Gillberg; Richard Delorme Journal: Autism Res Date: 2016-11-03 Impact factor: 5.216
Authors: Stephan J Sanders; Xin He; A Jeremy Willsey; A Gulhan Ercan-Sencicek; Kaitlin E Samocha; A Ercument Cicek; Michael T Murtha; Vanessa H Bal; Somer L Bishop; Shan Dong; Arthur P Goldberg; Cai Jinlu; John F Keaney; Lambertus Klei; Jeffrey D Mandell; Daniel Moreno-De-Luca; Christopher S Poultney; Elise B Robinson; Louw Smith; Tor Solli-Nowlan; Mack Y Su; Nicole A Teran; Michael F Walker; Donna M Werling; Arthur L Beaudet; Rita M Cantor; Eric Fombonne; Daniel H Geschwind; Dorothy E Grice; Catherine Lord; Jennifer K Lowe; Shrikant M Mane; Donna M Martin; Eric M Morrow; Michael E Talkowski; James S Sutcliffe; Christopher A Walsh; Timothy W Yu; David H Ledbetter; Christa Lese Martin; Edwin H Cook; Joseph D Buxbaum; Mark J Daly; Bernie Devlin; Kathryn Roeder; Matthew W State Journal: Neuron Date: 2015-09-23 Impact factor: 17.173
Authors: Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie Journal: Biol Psychiatry Date: 2009-11-07 Impact factor: 13.382
Authors: Felix D C C Beacher; Eugenia Radulescu; Ludovico Minati; Simon Baron-Cohen; Michael V Lombardo; Meng-Chuan Lai; Anne Walker; Dawn Howard; Marcus A Gray; Neil A Harrison; Hugo D Critchley Journal: PLoS One Date: 2012-06-12 Impact factor: 3.240
Authors: D M Osborne; U S Sandau; A T Jones; J W Vander Velden; A M Weingarten; N Etesami; Y Huo; H Y Shen; D Boison Journal: Neuropharmacology Date: 2018-08-23 Impact factor: 5.250
Authors: Lawrence K Fung; Ryan E Flores; Meng Gu; Kevin L Sun; David James; Rachel K Schuck; Booil Jo; Jun Hyung Park; Byung Chul Lee; Jae Ho Jung; Sang Eun Kim; Manish Saggar; Matthew D Sacchet; Geoff Warnock; Mohammad Mehdi Khalighi; Daniel Spielman; Frederick T Chin; Antonio Y Hardan Journal: Mol Psychiatry Date: 2020-05-06 Impact factor: 15.992
Authors: Ha Na Choe; Jeevan Tewari; Kevin W Zhu; Matthew Davenport; Hiroaki Matsunami; Erich D Jarvis Journal: Horm Behav Date: 2021-01-23 Impact factor: 3.587